SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-19-005680
Filing Date
2019-05-10
Accepted
2019-05-10 16:01:26
Documents
67
Period of Report
2019-05-10

Document Format Files

Seq Description Document Type Size
1 10Q v051019_10Q.htm 10-Q 1205050
2 EXHIBIT 31.1 exhibit31-1.htm EX-31 18122
3 EXHIBIT 31.2 exhibit31-2.htm EX-31 17976
4 EXHIBIT 32.1 exhibit32-1.htm EX-32 6659
5 EXHIBIT 32.2 exhibit32-2.htm EX-32 6844
  Complete submission text file 0001654954-19-005680.txt   3830343

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT tgtx-20190331.xml EX-101.INS 458726
7 XBRL TAXONOMY EXTENSION SCHEMA tgtx-20190331.xsd EX-101.SCH 47684
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tgtx-20190331_cal.xml EX-101.CAL 51736
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tgtx-20190331_def.xml EX-101.DEF 122026
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE tgtx-20190331_lab.xml EX-101.LAB 307883
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tgtx-20190331_pre.xml EX-101.PRE 239981
Mailing Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32639 | Film No.: 19814766
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1